Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
696 studies found for:    Open Studies | "Hematopoietic Stem Cells"
Show Display Options
Rank Status Study
21 Unknown  Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
Conditions: Hematopoietic Stem Cell Transplantation;   Mesenchymal Stem Cells;   Umbilical Cord Blood;   Graft Failure;   Hematological Diseases
Interventions: Biological: Mesenchymal stem cells;   Biological: Mesenchymal stem cells and cord blood
22 Recruiting Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: ATG
23 Recruiting Gut Decontamination In Pediatric Allogeneic Hematopoietic
Conditions: Hematopoietic Stem Cell Transplantation (HSCT);   Acute GVH Disease
Intervention: Drug: Vancomycin-polymyxin B
24 Recruiting Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation;   Myeloablative;   Delayed Platelet Engraftment
Intervention: Drug: Recombinant Human Thrombopoietin (rHTPO)
25 Recruiting A Pharmacokinetic Study of Melphalan in Children
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: Melphalan
26 Not yet recruiting MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT
Conditions: Minimal Residual Disease;   Donor Lymphocyte Infusion;   Hematopoietic Stem Cell Transplantation;   Relapse
Interventions: Biological: donor lymphocyte infusion;   Drug: Cyclosporine A
27 Unknown  Oral Selenium Therapy for the Prevention of Mucositis
Conditions: Mucositis;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Oral selenium;   Drug: Oral placebo
28 Recruiting TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
Conditions: Primary Immune Deficiency Disorder;   Hematopoietic Stem Cell Transplantation
Intervention: Other: Biological: TCR alfa beta T cell depletion
29 Unknown  Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
Conditions: Invasive Fungal Infection;   Aspergillosis;   Fungemia;   Hematopoietic Stem Cell Transplantation
Intervention:
30 Recruiting Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS);   Hematopoietic Stem Cell Transplant (HSCT)
Interventions: Drug: Reduced-Intensity Conditioning Regimen;   Drug: Myeloablative Conditioning Regimen
31 Recruiting Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
Conditions: Hematopoietic Stem Cell Transplantation;   Vancomycin-Resistant Enterococci
Interventions: Other: Theraworx™ bath wipes;   Other: Standard bath wipes
32 Not yet recruiting Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT
Conditions: Myelodysplastic Syndrome;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Drug: Decitabine;   Drug: CAG chemotherapy regimen;   Drug: G-CSF+Decitabine+BUCY Conditioning Regimen
33 Recruiting Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Hodgkins Lymphoma;   Non-Hodgkins Lymphoma
Intervention:
34 Recruiting The Collection and Storage of Umbilical Cord Blood for Transplantation
Conditions: Cord Blood Stem Cell Transplantation;   Cord Blood Transplantation;   Hematopoietic Stem Cell Transplantation
Intervention:
35 Recruiting Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
Conditions: Hematopoietic Stem Cell Transplant;   Bone Marrow Transplant
Intervention: Drug: Zoledronic acid
36 Recruiting Intrabone Infusion of Umbilical Cord Blood Stem Cells
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Procedure: Intrabone infusion of umbilical cord blood stem cells
37 Recruiting Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Conditions: Graft-versus-host Disease;   Hematopoietic Stem Cell Transplantation
Interventions: Drug: Maraviroc;   Drug: Cyclosporine (in HLA-Unrelated Donor Transplantation);   Drug: Tacrolimus (in HLA-Mismatched Related Donor Transplantation);   Drug: Methotrexate
38 Unknown  Exercise in Pediatric Autologous Stem Cell Transplant Patients
Conditions: Cancer;   Autologous Hematopoietic Stem Cell Transplantation
Interventions: Other: EXERCISE (EX);   Other: Standard Care
39 Recruiting Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
Conditions: Leukemia;   Transplantation, Hematopoietic Stem Cell
Intervention: Drug: Caspofugin based combination therapy
40 Not yet recruiting Hematopoietic Stem Cell Microtransplantation for in AML
Condition: Acute Myeloid Leukemia
Interventions: Procedure: hematopoietic stem cell microtransplantation-long-term;   Procedure: hematopoietic stem cell microtransplantation-short-term;   Drug: Conditioning for CR group;   Drug: Conditioning for Non-CR group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years